Factors Associated with Opioid-Related Fatal and Non-fatal Overdose
|
|
- Georgiana Matthews
- 5 years ago
- Views:
Transcription
1 Factrs Assciated with Opiid-Related Fatal and Nn-fatal Overdse Understanding the factrs assciated with piid-related fatal and nn-fatal verdse and can help practitiners assess, plan fr, and select interventins t address them. Researchers have identified a variety f factrs that place individuals at increased risk fr piid verdse (and death in the event f an verdse). These can be rganized int the fllwing categries: Opiid Use and Misuse Ability t Prcess Opiids Chrnic Pain and Mental Health Opiid Access and Supply Opiid Knwledge and Perceptins Nn-fatal Overdse OPIOID USE AND MISUSE Bth medical and illicit use f piids can place individuals a risk f fatal and nn-fatal verdse. Risk factrs assciated with the medical use f prescriptin piids include: Prescriptins that are lng-term, r fr high dses r lng-acting piids Having cncurrent prescriptins (fr example, fr multiple piids r fr bth piids and benzdiazepines) Risk factrs assciated with the illicit use f any piids include: Nn-medical use f prescriptin piids Use f herin and ther nn-prescriptin piids Illicit use f piids in cmbinatin with ther cntrlled substances (similar t medical use) PAGE 1 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 1
2 Finally, use f piids alne (withut ther individuals arund t respnd) is assciated with increased risk f death in the event f an verdse. ABILITY TO PROCESS OPIOIDS An individual s ability t physically prcess an piid is influenced by several factrs that can increase ne s risk fr fatal r nn-fatal verdse: piid dependence, changes in piid tlerance, and cmprmised physical health. Opiid dependence, a physical adaptatin t piids that prduces withdrawal symptms when piid use stps, may lead t piid misuse r additin, which is assciated with increased verdse risk Risk factrs assciated with piid tlerance (the bdy s ability t prcess and experience the effects f a certain amunt f a substance) include: An increase in tlerance (needing mre f a drug in rder t experience the same effect) Decrease in tlerance with time away frm use (due t hspitalizatin, treatment, r incarceratin) Risk factrs assciated with physical health prblems include: A cmprmised immune system Pulmnary dysfunctin (including lung damage and disrders such as asthma, emphysema, r sleep apnea) Liver dysfunctin CHRONIC PAIN AND MENTAL HEALTH In additin t the physical health factrs that may influence an individual s ability t prcess piids, several ther physical and mental health issues as assciated with an increased risk fr piidrelated fatal and nn-fatal verdse. Chrnic pain, defined as pain that lasts lnger than 3 mnths r past the time an injury is expected t heal Mental health disrders, including depressin, anxiety, and/r substance use disrders Risk factrs assciated with adverse life experiences include: Having witnessed a family member verdse Financial struggles, including unemplyment Hmelessness PAGE 2 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 2
3 OPIOID ACCESS AND SUPPLY Factrs that increase the availability f prescriptin and nn-prescriptin piids such as piid prescribing practices, diversin f prescriptin piids, and changes in the lcal drug supply as assciated with increased risk fr fatal and nn-fatal verdse. Risk factrs assciated with piid prescribing practices include: Increases in piid dsage and/r duratin f use, and number f pills prescribed (that is, days supply) Increases in the number f piid prescriptins written The diversin f prescriptin piids r redirectin f cntrlled substances frm their lawful purpse t illicit use is assciated with increased risk fr piid-related verdse. Prescriptin drugs can be diverted thrugh peple such as: Friends r relatives Healthcare prviders Drug dealers Risk factrs assciated with changes in the lcal drug supply include: Increases in the availability and decreases in the cst f herin Increases in the purity f herin Increases in the number f street drugs, including herin, testing psitive fr fentanyl and ther ptent piids OPIOID KNOWLEDGE AND PERCEPTIONS An individual s lack f knwledge abut piids and risks assciated with their misuse, including verdse, and their perceptins twards these drugs can place them at increased risk fr verdse. Risk factrs assciated with piid knwledge and perceptins include: A lack f understanding r awareness f verdse risks (such as the risks assciated with using piids and ther substances cncurrently) A lw perceptin f the harms assciated with piids, specifically prescriptin piids NON-FATAL OVERDOSE Experiencing a nn-fatal piid verdse in the past increases peple s risk f suffering a fatal verdse in the future. PAGE 3 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 3
4 Risk factrs assciated with nn-fatal verdse include: The specific factrs that caused the initial verdse, including high-risk piid misuse. Any physical health prblems caused by the verdse itself, which may include damage t the brain, heart, liver, r kidneys. REFERENCES Baumblatt, J. A. G., Wiedeman, C., Dunn, J. R., Schaffner, W., Paulzzi, L. J., & Jnes, T. F. (2014). High-risk use by patients prescribed piids fr pain and its rle in verdse deaths. JAMA Internal Medicine, 174(5), Betts, K. S., McIlwraith, F., Dietze, P., Whittaker, E., Burns, L., Cgger, S., & Alati, R. (2015). Can differences in the type, nature r amunt f plysubstance use explain the increased risk f nn-fatal verdse amng psychlgically distressed peple wh inject drugs? Drug and Alchl Dependence, 154, Bhnert, A. S. B., Valenstein, M., Bair, M. J., Ganczy, D., McCarthy, J. F., Ilgen, M. A., & Blw, F. C. (2011). Assciatin Between Opiid Prescribing Patterns and Opiid Overdse-Related Deaths. JAMA, 305(13), Bnar, E. E., & Bhnert, A. S. (2016). Perceived severity f and susceptibility t verdse amng injectin drug users: Relatinships with verdse histry. Substance Use & Misuse, 51(10), Green, T. C., Black, R., Grimes Serran, J. M., Budman, S. H., & Butler, S. F. (2011). Typlgies f prescriptin piid use in a large sample f adults assessed fr substance abuse treatment. PLOS ONE, 6(11), e Jhnsn, E. M., Lanier, W. A., Merrill, R. M., Crk, J., Prucznik, C. A., Rlfs, R. T., & Sauer, B. (2013). Unintentinal prescriptin piid-related verdse deaths: descriptin f decedents by next f kin r best cntact, Utah, Jurnal f General Internal Medicine, 28(4), Kinner, S. A., Milly, M. J., Wd, E., Qi, J., Zhang, R., & Kerr, T. (2012). Incidence and risk factrs fr nn-fatal verdse amng a chrt f recently incarcerated illicit drug users. Addictive Behavirs, 37(6), Neira-León, M., Barri, G., Brav, M. J., Brugal, M. T., de la Fuente, L., Dming-Salvany, A., Pulid, J., Sants, S., & Prject Itinere Grup. (2011). Infrequent piid verdse risk reductin behaviurs amng yung adult herin users in cities with wide cverage f HIV preventin prgrammes. Internatinal Jurnal f Drug Plicy, 22(1), Peirce, G. L., Smith, M. J., Abate, M. A., & Halversn, J. (2012). Dctr and pharmacy shpping fr cntrlled substances. Medical Care, 50(6), Riley, E. D., Evans, J. L., Hahn, J. A., Bricen, A., Davidsn, P. J., Lum, P. J., & Page, K. (2016). A lngitudinal study f multiple drug use and verdse amng yung peple wh inject drugs. American Jurnal f Public Health, 106(5), Siegler, A., Tuazn, E., Bradley O Brien, D., & Pane, D. (2014). Unintentinal piid verdse deaths in New Yrk City, : A place-based apprach t reduce risk. Internatinal Jurnal f Drug Plicy, 25(3), Silva, K., Schrager, S. M., Kecjevic, A., & Lankenau, S. E. (2013). Factrs assciated with histry f nn-fatal verdse amng yung nnmedical users f prescriptin drugs. Drug and Alchl Dependence, 128(1-2), PAGE 4 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 4
5 Yarbrugh, B. J., Stumb, S. P., Janff, S. L., Yarbrugh, M. T., McCarty, D., Chilcat, H. D., Cplan, P. M., & Green, C. A. (2016 ). Understanding piid verdse characteristics invlving prescriptin and illicit piids: A mixed methds analysis. Drug and Alchl Dependence, 167, Yang, Z., Wilsey, B., Bhm, M., Weyrich, M., Ry, K., Ritley, D., Jnes, C., & Melnikw, J. (2015). Defining risk f prescriptin piid verdse: pharmacy shpping and verlapping prescriptins amng lng-term piid users in medicaid. The Jurnal f Pain, 16(5), Zedler, B., Xie, L., Wang, L., Jyce, A., Vick, C., Karibury, F., Rajan, P., Baser, O., & Murrelle, L. (2014). Risk factrs fr serius prescriptin piid-related txicity r verdes amng Veterans Health Administratin patients. Pain Medicine, 15(11), Zedler, B., Xie, L., Wang, L., Jyce, A., Vick, C., Brigham, J., Karibury, F., Baser, O., & Murrelle, L. (2015). Develpment f a risk index fr serius prescriptin piid-induced respiratry depressin r verdse in Veterans Health Administratin patients. Pain Medicine, 16(8), PAGE 5 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 5
2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More informationThank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!
Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please
More informationThe Role of Prevention in Addressing Opioid Overdose
CAPT TRAINING October 10, 2017 The Role of Prevention in Addressing Opioid Overdose Trainers: Erin Haas, MPH, CAPT Associate Hayden D. Center, Jr., Ph.D., L.P.C, CAPT Associate Technical Information This
More informationPennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain
Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre
More informationAttachment 3. Efforts to Address the Opioid Epidemic in Clark County
Attachment 3 Effrts t Address the Opiid Epidemic in Clark Cunty Overview Backgrund Current wrk SNHD Challenges Next Steps Backgrund Drug verdses are nw the leading cause f death amng Americans under 50
More informationOrange County Heroin Task Force: A targeted approach to improving outcomes
Orange Cunty Herin Task Frce: A targeted apprach t imprving utcmes Christpher Hunter, M.D., Ph.D. Directr, Orange Cunty Health Services Department Assciate Medical Directr, Orange Cunty EMS System Cntents
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationMedication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets
Medicatin Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets IMPORTANT: D nt use ABSTRAL unless yu are regularly using anther piid pain medicine arund-the-clck fr at least ne week r lnger fr yur
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationMedication Assisted Treatment for Opioid Use Disorder in Rural Colorado
Medicatin Assisted Treatment fr Opiid Use Disrder in Rural Clrad Why is piid use disrder getting s much attentin? Opiid Use Disrder (OUD) has seen an epidemic rise in the United States ver the past decade.
More informationMedicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes
Medicare Advantage 2019 Advance Ntice Part 1 21 st Century Cures Act Methdlgical Changes Review f Relevant Prvisins with Expert Insight January 2018 PULSE8 is privileged t bring yu a summary f key Medicare
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationOpioid Analgesics PA Request Provider Checklist
WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin
More informationEXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION
EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationImproving Surveillance and Monitoring of Self-harm in Irish Prisons
HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June
More information3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?
3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:
More informationMethadone Maintenance Treatment for Opioid Dependence
POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin
More informationLEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST
OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED
More informationMEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache
MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management
More informationThe data refer to persons aged between 15 and 54.
Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing
More informationTop 10 Causes of Disability
Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins
More informationTHE DANISH HARM REDUCTION MODEL
THE DANISH HARM REDUCTION MODEL OUTLINE 1. Drug use and drug prblems in Denmark. 2. Danish drug plicy. 3. Danish harm reductin plicy. 4. Drug cnsumptin facilities. DANISH DRUG POLICY Drug plicy can be
More informationIntroduction. Forensic toxicology helps determine cause-and-effect relationships. Toxic or lethal effects from that exposure. between.
1 Drugs and Txins Intrductin Frensic txiclgy helps determine cause-and-effect relatinships between Expsure t a drug r ther substance and Txic r lethal effects frm that expsure 2 Frensic Science: Fundamentals
More informationSupporting Psychosocial Health and Resilience in Liberia. Japanese Social Development Fund The World Bank 4 March, 2015
Supprting Psychscial Health and Resilience in Liberia Japanese Scial Develpment Fund The Wrld Bank 4 March, 2015 Summary Cntext Mental Heath and Psychscial Impact f EVD Prject Overview Prject Objectives
More informationOntario s Referral and Listing Criteria for Adult Lung Transplantation
Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationOriginal Policy Date 12:2013
MP 5.01.18 Xlair (Omalizumab) Medical Plicy Sectin Prescriptin Drugs Issu12:2013e 4:2006 Original Plicy Date 12:2013 Last Review Status/Date Lcal plicy/12:2013 Return t Medical Plicy Index Disclaimer Our
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More information454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place
MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and
More informationMINISTRY OF HEALTH INFORMATION BRIEFING NOTE
Cliff # 980489 MINISTRY OF HEALTH INFORMATION BRIEFING NOTE. PREPARED FOR: Graham Whitmarsh, Deputy Minister, Ministry f Health Heather Davidsn, ADM, Planning and Innvatin Divisin FOR INFORMATION TITLE:
More informationYoung Hackney Substance Misuse Service
Yung Hackney Substance Misuse Service Needs Assessment The Needs Assessment carried ut in 2014 highlighted the fllwing key areas fr imprvement and develpment: Lack f existing service prvisin fr 19 25 year
More informationSTRATEGIC PLAN APRIL 2018
STRATEGIC PLAN APRIL 2018 LANCASTER COUNTY JOINING FORCES INFORMATION DISCLAIMER Lancaster Cunty Jining Frces emphasizes the principles f transparency, accuntability, cllabratin, and partnership. We are
More informationThe policy was formulated through consultation between members of staff, governors, parents and pupils.
VALENCE PRIMARY SCHOOL Fd and Drink Plicy INTRODUCTION Valence Primary Schl is dedicated t prmting healthy lifestyles and prviding an envirnment that prmtes healthy eating and drinking, enabling pupils
More informationS.K.J Construction Ltd Groundwork & Civil Engineering
S.K.J Cnstructin Ltd Grundwrk & Civil Engineering SUBSTANCE MISUSE POLICY 1 2 SUBSTANCE MISUSE POLICY 1 INTRODUCTION Plicy Aims Frm the viewpint f health and safety at wrk, SKJ Cnstructin Ltd (the Cmpany)
More informationFTD RESEARCH: The Value of Studies and Opportunities for Involvement
FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver
More informationPrescribing Safely to Prevent Misuse & Diversion
Patient-Prvider Agreement fr Onging Use f Cntrlled Medicatin BIRTHDATE: NAME: The use f the fllwing medicine(s) (list medicine names) Is nly ne part f my treatment fr. Primary Prescribing Dctr: What shuld
More informationIll Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary
Unit 11: Understand Mental Ill Health Unit reference number: L/616/7295 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 16 Unit summary Mental ill health culd be ne f the mst serius health
More informationVaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE
Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationStandard Statement Content Words Essential Questions Knowledge and/or Skill Topic Assessment A. Analyze factors that impact growth and development
Curse: Health Grade: Grade 7 State Standard: 10.1.9 Cncepts f Health Time Frame: 20-22 Lessns Standard Statement Cntent Wrds Essential Questins Knwledge and/r Skill Tpic Assessment A. Analyze factrs that
More informationCHAPTER 2. HEALTH SERVICES
CHAPTER 2. HEALTH SERVICES 2.1 Treatment f substance use disrders within health services Thmas F Babr and Kerstin Stenius Overview Since the end f the Secnd Wrld War there has been a cnsistent grwth f
More informationState Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1
State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan
More informationCancer Association of South Africa (CANSA)
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.
More informationAdvantage EAP Employee Assistance Program
Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse
More informationIowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training
Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.
More informationPART III: CONSUMER INFORMATION
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationThese are medical emergencies that can cause death. If possible, remove OTFC from the mouth.
MEDICATION GUIDE Oral Transmucsal Fentanyl Citrate (OTFC) CII (fentanyl citrate) ral transmucsal lzenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: D nt use Oral Transmucsal Fentanyl
More informationPolicy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)
Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/1/18 Applied Behaviral Analysis (ABA) This medical plicy will apply t self-funded grups upn their renewal, beginning 1/1/18. Des nt apply t BlueCare.
More informationFlu Season Key Points ( )
2014-2015 Flu Seasn Key Pints (10-31-14) Cntents Overarching Framewrk f CDC Influenza Messaging... 3 Take 3 Messages... 3 Statements fr General Audiences... 4 Disease... 4 Vaccinatin... 6 Vaccinatin Timing...
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationEAST VALLEY DERMATOLOGY CENTER
EAST VALLEY DERMATOLOGY CENTER Adult and Pediatric Dermatlgy VALLEY SKIN CANCER SURGERY PATIENT INFORMATION RECORD Please Use Black Ink Only Patient Infrmatin Patient s Name Last First Middle Initial Address
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationPsychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen
Psychlgical aspects f breast cancer Dr Carline Dancyger & Dr Esther Hansen Cmmn acrss all cancers Adjustment as the nrm Diagnsis End f active treatment r Discharge Palliative Care Recurrence distress t
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationFIGHT DEMENTIA ACTION PLAN
FIGHT DEMENTIA ACTION PLAN DEMENTIA IS A HEALTH PRIORITY Dementia will be the majr health prblem f this century. Over ne millin Australians are already affected by the disease themselves r are caring fr
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationEXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS
1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics
More informationPATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.
PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr
More informationITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.
Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet
More information/0515 Medication Guide Aripiprazole Tablets
8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This
More informationForensic Science: Fundamentals & Investigations, 2e Chapter 9. All rights Reserved Cengage/NGL/South-Western 2016
1 Frensic Science: Fundamentals & Investigatins, 2e Cengage/NGL/Suth-Western 2016 Frensic Txiclgy By the end f this chapter yu will be able t: 9.1 Prvide examples f drugs, pisns, and txins. 9.2 List factrs
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationMeeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C
Cmmnwealth f Kentucky Cabinet fr Health and Family Services Department fr Medicaid Services Drug Management Review Advisry Bard Meeting May 12, 2011 Meeting Minutes Vting Members in attendance: Kim Crley,
More informationCreating and Linking Charge Objects
Overview Charge bject screens are used t maintain cst accunting cdes that agencies use t break ut emplyee time based n wrk perfrmed and leave time while assigned t a specific prject(s). The charge bject
More informationNovel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.
Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute
More informationEvaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief
Evaluatin f a Shared Decisin Making Interventin between Patients and Prviders t Imprve Menpause Health Outcmes: Issue Brief Key Findings Tablet technlgy can be successfully incrprated int primary practices
More informationPreventing Suicide: Review of Safety Protocol for Suicidal Students. Maureen Cooper Jamie Anderson
Preventing Suicide: Review f Safety Prtcl fr Suicidal Students Maureen Cper Jamie Andersn Fast Facts abut Suicide 2013, students in grades 9-12: 17% seriusly cnsidered attempting suicide in the previus
More informationDrug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD)
Drug Class Review: Lng-acting muscarinic antagnists (LAMAs) fr treatment f chrnic bstructive pulmnary disease (COPD) Cmprehensive Research Plan: Pharmacepidemilgy Unit April 10 th, 2014 ODPRN Drug Class
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.
More informationBARNSLEY BUSINESS DELIVERY UNIT COMMUNITY SUBSTANCE MISUSE TEAM
1.0 APPLICABLE TO Barnsley specialist Business Delivery Unit. Cmmunity Alchl & Substance Misuse Team Suth West Yrkshire Partnership NHS Fundatin Trust 2.0 RISK FACTORS Reduced piid tlerance and accidental
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationPart 1 describes the reasoning and recommendations up to node 2 of the algorithm.
Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationChronic Non Malignant Pain - Strong Opioid Prescribing Guideline and Educational Pack
Appendix 4G Chrnic Nn Malignant Pain - Strng Opiid Prescribing Guideline and Educatinal Pack Backgrund Opiids have been increasingly prescribed t treat chrnic nn malignant pain. There is evidence frm clinical
More informationCandida March, Ines Smyth, and Maitrayee Mukhopadhyay, 1999, A Guide to Gender-Analysis Frameworks, London: Oxfam Publishing.
GENDER ANALYSIS FRAMEWORKS There are many mdels and framewrks. N single framewrk prvides an apprpriate way t address all develpment issues Each mdel reflects a set f assumptins abut what gender means and
More informationA. Catalonia World Health Organization Demonstration Project
A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin
More informationMEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV
MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.
More informationSeeking and Appraising Evidence
EWMA Educatinal Develpment Prgramme Curriculum Develpment Prject Educatin Mdule: Seeking and Appraising Evidence Latest review: August 2012 Educatin Mdule: Seeking and Appraising Evidence ABOUT THE EWMA
More informationof Communication and Interactions with Individuals who have Dementia
Unit 15: Understanding the Rle f Cmmunicatin and Interactins with Individuals wh have Dementia Unit reference number: H/616/7299 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 26 Unit
More informationSub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate
Nte: Feedback frm prfessin stakehlders n the first draft f the Entry-Level Massage Educatin Blueprint indicated that this sub-tpic was beynd entry-level r unnecessary fr safe and cmpetent practice. The
More informationSURGICAL NOTE. Surgical Recommendations to Optimize Femoral/Iliac Artery Cannulation
SURGICAL NOTE Surgical Recmmendatins t Optimize Femral/Iliac Artery Cannulatin Due t its size, lcatin, and ease f access, the femral artery is frequently used fr bld pressure catheter placement. Less frequently,
More informationEvaluation of Hunter & New England HealthPathways
Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%
More informationACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.
27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000
More informationOTHER AND UNSPECIFIED DISORDERS
OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationSocial Learning Theories
Scial Learning Theries - Careful scientific prcedures and methdlgy that characterize the behaviurist apprach Albert Bandura - Brn in small twn Alberta - Plish decent - Only sn with 5 sisters - Interested
More informationNUCYNTA ER (tapentadol extended-release tablets) Fact Sheet
NUCYNTA ER (tapentadl extended-release tablets) Fact Sheet What is NUCYNTA ER (prnunced 'new-sinn-tah')? NUCYNTA ER (tapentadl extended-release tablets), an ral analgesic taken twice daily, is nw apprved
More informationCDC Influenza Division Key Points November 7, 2014
In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More information